Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.18B |
| 2 |
Apple
AAPL
|
+$1.11B |
| 3 |
Broadcom
AVGO
|
+$562M |
| 4 |
Amazon
AMZN
|
+$553M |
| 5 |
Palo Alto Networks
PANW
|
+$485M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$246M |
| 2 |
O'Reilly Automotive
ORLY
|
+$149M |
| 3 |
Cadence Design Systems
CDNS
|
+$149M |
| 4 |
Synopsys
SNPS
|
+$134M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.24% |
| 2 | Healthcare | 13.33% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Vor Biopharma
VOR
$1.15B
| $2.23M | ﹤0.01% |
36,120
+20,323
| +129% | +$1.86M |
|
3077
Veritone
VERI
$101M
| $2.23M | ﹤0.01% |
568,866
-33,407
| -6% | -$146K |
|
3078
NI Holdings
NODK
$310M
| $2.23M | ﹤0.01% |
150,065
+675
| +0.5% | +$9.19K |
|
3079
Pulse Biosciences
PLSE
$2.43B
| $2.22M | ﹤0.01% |
308,513
+166,023
| +117% | +$1.06M |
|
|
NGM
3080
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $2.2M | ﹤0.01% |
850,956
+60,119
| +8% | +$214K |
|
3081
P3 Health Partners
PIII
$32.7M
| $2.2M | ﹤0.01% |
14,705
+4,314
| +42% | +$596K |
|
3082
Kopin
KOPN
$652M
| $2.2M | ﹤0.01% |
1,021,743
+164,654
| +19% | +$247K |
|
3083
Kornit Digital
KRNT
$705M
| $2.19M | ﹤0.01% |
74,405
+2,851
| +4% | +$64.4K |
|
3084
Consumer Portfolio Services
CPSS
$202M
| $2.18M | ﹤0.01% |
186,501
+8,995
| +5% | +$97.3K |
|
|
BLDP
3085
Ballard Power Systems
BLDP
$805M
| $2.17M | ﹤0.01% |
495,938
-5,254
| -1% | -$23.9K |
|
3086
AirSculpt Technologies
AIRS
$339M
| $2.16M | ﹤0.01% |
250,558
+18,476
| +8% | +$121K |
|
|
PSTX
3087
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.16M | ﹤0.01% |
1,224,567
+718,477
| +142% | +$1.84M |
|
3088
Xenon Pharmaceuticals
XENE
$6.06B
| $2.15M | ﹤0.01% |
55,915
+190
| +0.3% | +$7.55K |
|
|
QIPT
3089
DELISTED
Quipt Home Medical
QIPT
| $2.15M | ﹤0.01% |
402,803
+384,448
| +2,095% | +$2.27M |
|
|
LLAP
3090
DELISTED
Terran Orbital Corporation
LLAP
| $2.15M | ﹤0.01% |
1,430,444
+505,202
| +55% | +$800K |
|
3091
Beyond Air
XAIR
$3.8M
| $2.14M | ﹤0.01% |
1,254
+605
| +93% | +$1.38M |
|
3092
Vermilion Energy
VET
$1.82B
| $2.13M | ﹤0.01% |
143,657
+9,133
| +7% | +$113K |
|
3093
Genelux
GNLX
$132M
| $2.13M | ﹤0.01% |
65,038
+27,329
| +72% | +$769K |
|
3094
Offerpad Solutions
OPAD
$18.3M
| $2.12M | ﹤0.01% |
16,387
+6,617
| +68% | +$556K |
|
3095
USCB Financial Holdings
USCB
$406M
| $2.11M | ﹤0.01% |
206,992
+723
| +0.4% | +$7.11K |
|
|
KWY
3096
Kingsway Corp
KWY
$255M
| $2.11M | ﹤0.01% |
258,685
+108,054
| +72% | +$924K |
|
|
SHCO
3097
DELISTED
Soho House & Co
SHCO
| $2.1M | ﹤0.01% |
388,309
-7,119
| -2% | -$44.9K |
|
3098
Vitamin Cottage Natural Grocers
NGVC
$739M
| $2.1M | ﹤0.01% |
171,448
+3,560
| +2% | +$40.1K |
|
3099
Willis Lease Finance
WLFC
$1.7B
| $2.09M | ﹤0.01% |
160,440
+80,955
| +102% | +$1.25M |
|
3100
Rush Enterprises Class B
RUSHB
$6.04B
| $2.09M | ﹤0.01% |
46,015
+2,079
| +5% | +$84.1K |
|
Similar funds
Geode Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
- Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
- Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
- Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
- Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
- Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.